TY - JOUR
T1 - Development and external validation of a nomogram for prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis
AU - Fukuda, Rintaro
AU - Hakuta, Ryunosuke
AU - Nakai, Yousuke
AU - Hamada, Tsuyoshi
AU - Takaoka, Shinya
AU - Tokito, Yurie
AU - Suzuki, Yukari
AU - Oyama, Hiroki
AU - Kanai, Sachiko
AU - Noguchi, Kensaku
AU - Suzuki, Tatsunori
AU - Ishigaki, Kazunaga
AU - Saito, Kei
AU - Saito, Tomotaka
AU - Takahara, Naminatsu
AU - Mizuno, Suguru
AU - Ito, Yukiko
AU - Kogure, Hirofumi
AU - Fujishiro, Mitsuhiro
N1 - Publisher Copyright:
© 2023 IAP and EPC
PY - 2023/11
Y1 - 2023/11
N2 - Background and aims: Endoscopic retrograde cholangiopancreatography (ERCP) is widely performed for management of pancreatobiliary diseases; however, post-ERCP pancreatitis (PEP) remains as an unsolved problem. Although various risk factors for PEP have been reported, the prediction of PEP remains controversial. This study aimed to develop a predictive model for PEP. Methods: Consecutive patients undergoing ERCP for biliary indications at two centers were retrospectively studied. Using data from a training cohort, we utilized a multivariable model to select five variables to construct a nomogram. The predictive model was internally and externally validated. Based on the nomogram, the patients were categorized into low-, moderate-, and high-risk groups. Results: Using the data of 2224 patients in the training cohort, five variables were selected to generate a nomogram: 1) sex, 2) indication for ERCP, 3) difficult cannulation, 4) guidewire insertion into the pancreatic duct, and 5) endoscopic sphincterotomy or sphincteroplasty. The most significant risk factor was endoscopic papillary balloon dilation such as endoscopic sphincterotomy or sphincteroplasty. The bias-corrected concordance index was 0.72 in the training cohort and 0.72 in the validation cohort. Calibration curves for both cohorts demonstrated good agreement between the predicted and observed frequencies of the actual outcome. In the validation cohort, PEP developed in 5.0% and 14% of patients in the moderate- and high-risk groups, respectively. Conclusions: We successfully developed a good predictive model for PEP. The prevention of PEP in high risk patients should be investigated further.
AB - Background and aims: Endoscopic retrograde cholangiopancreatography (ERCP) is widely performed for management of pancreatobiliary diseases; however, post-ERCP pancreatitis (PEP) remains as an unsolved problem. Although various risk factors for PEP have been reported, the prediction of PEP remains controversial. This study aimed to develop a predictive model for PEP. Methods: Consecutive patients undergoing ERCP for biliary indications at two centers were retrospectively studied. Using data from a training cohort, we utilized a multivariable model to select five variables to construct a nomogram. The predictive model was internally and externally validated. Based on the nomogram, the patients were categorized into low-, moderate-, and high-risk groups. Results: Using the data of 2224 patients in the training cohort, five variables were selected to generate a nomogram: 1) sex, 2) indication for ERCP, 3) difficult cannulation, 4) guidewire insertion into the pancreatic duct, and 5) endoscopic sphincterotomy or sphincteroplasty. The most significant risk factor was endoscopic papillary balloon dilation such as endoscopic sphincterotomy or sphincteroplasty. The bias-corrected concordance index was 0.72 in the training cohort and 0.72 in the validation cohort. Calibration curves for both cohorts demonstrated good agreement between the predicted and observed frequencies of the actual outcome. In the validation cohort, PEP developed in 5.0% and 14% of patients in the moderate- and high-risk groups, respectively. Conclusions: We successfully developed a good predictive model for PEP. The prevention of PEP in high risk patients should be investigated further.
KW - Cholangiopancreatography
KW - Endoscopic retrograde
KW - Nomograms
KW - Pancreatitis
UR - http://www.scopus.com/inward/record.url?scp=85169505509&partnerID=8YFLogxK
U2 - 10.1016/j.pan.2023.08.008
DO - 10.1016/j.pan.2023.08.008
M3 - Article
C2 - 37666733
AN - SCOPUS:85169505509
SN - 1424-3903
VL - 23
SP - 789
EP - 796
JO - Pancreatology
JF - Pancreatology
IS - 7
ER -